🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Increased mammographic density is recognized as an important risk factor fo...
Status
Completed
Location
Mayo Clinic in Rochester
Start Date
2010-11
Trial ID
NCT01240278
This is a study looking at advanced imaging such as PET/CT and MRI to see i...
Status
Completed
Location
Central New York PET Center
Start Date
2002-01
Trial ID
NCT00639535
The purpose of this study is to show that improvements in the molecular bre...
Status
Completed
Location
Mayo Clinic
Start Date
2010-03
Trial ID
NCT01285440
This is a prospective study evaluating the role of Positron Emission Tomogr...
Status
Completed
Location
National Cancer Institute (NCI)
Start Date
1994-05
Trial ID
NCT00001385
We aim to determine if Molecular Breast Imaging (a new nuclear medicine tec...
Status
Completed
Location
Mayo Clinic
Start Date
2003-08
Trial ID
NCT00620087
Treatments Being Tested
The investigators hope to prove that radiation and surgical scarring does n...
Status
Completed
Location
Mayo Clinic
Start Date
2009-05
Trial ID
NCT01027767
Treatments Being Tested
This clinical trial studies technetium Tc-99m sestamibi molecular breast im...
Status
Active Not Recruiting
Location
University of Texas MD Anderson Cancer Center
Start Date
2015-06-15
Trial ID
NCT02324387
Treatments Being Tested
This study compares molecular breast imaging (MBI) and digital breast tomos...
Status
Completed
Location
Henry Ford Hospital
Start Date
2017-06-14
Trial ID
NCT03220893
Treatments Being Tested
A prospective cohort study design will be conducted. Patients with LABC who...
Status
Unknown
Location
Cancer institute
Start Date
2015-09
Trial ID
NCT02556684
To evaluate the diagnostic performance of Tc99m sestamibi (MBI) compared to...
Status
Recruiting
Location
M D Anderson Cancer Center
Start Date
2021-12-13
Trial ID
NCT05042687
Treatments Being Tested